Comparative Molecular Dynamics Reveals How LRRK2 Inhibitors Distinguish G2019S from Wild-Type
2025
No anti-IgLON5 antibody in carefully diagnosed PSP patients with "atypical" or variant clinical features
2025
Clinical and functional evidence for the pathogenicity of the <i>LRRK2</i> p.Arg1067Gln variant
2025
New insights from a Malaysian real-world deep brain stimulation cohort
2025
Frequency and Clinical Phenotype of Parkinson's Disease with the Asian LRRK2 p.G2385R and p.R1628P Risk Variants
2025
Interrogating LRRK2 Kinase Activity in Human Monocytes Derived from Parkinson's Disease Patients Carrying the Asian LRRK2 G2385R and R1628P Variants
2013
The role of LMTK3 in breast cancer cell growth and invasion
2010
Aqueous extract of Rodgersia sambucifolia suppress on the natural killer cell activity in normal subjects and recurrent spontaneous aborters
